We are currently seeking a full-time (Senior) Manager Biostatistics*. You will work in Tübingen or hybrid as part of our Translational Science Team in an interdisciplinary environment with very close contact to other clinical departments as well as various non-clinical departments across the global company and will contribute to our mission of developing new cancer immunotherapies to improve clinical outcomes for patients. Tübingen is a vibrant University city close to Stuttgart in the south of Germany.
This is a permanent position.
Your main responsibility will include but are not limited to the following tasks:
- Biostatistical lead for one or more clinical trials and responsible for planning, set-up, execution and quality control of statistical outputs (tables, figures, listings) based on clinical trial data, generating respective texts and discussing results in a cross-functional team to support the development of our drug candidates:
- Report safety data
- Contribute to writing of clinical and regulatory study documents
- Answer translational/ exploratory questions
- Contribute to publication of clinical trial data
- Provide support across all statistical tasks during the lifecycle of our programs, including clinical study protocol design, statistical analysis plan (SAP) development and the preparation of interim data readouts and finally the clinical study report.
- Support the accurate and complete data collection in the clinical EDC systems in close collaboration with the data management team.
- Oversee accurate completion of biostatistical outputs (SDTM, ADaM, TFLs) generated by external vendors, ensuring that the expected standards are met and that the outputs are in line with the analyses described in the protocol and SAP.
- Contribute to improving data analysis workflows, as well as implementing and executing quality measures to ensure data integrity, in close collaboration with other clinical teams.
- You hold a master's degree or PhD in statistics, data science, life science or in a related field, ideally with a focus on clinical biostatistics and statistical programming.
- Minimum of 2+ years of industry experience in analysis and reporting of clinical trial data.
- You exhibit a great attention to detail with strong affinity to answer scientific questions.
- Hands-on experience in programming in SAS, R, SQL and good programming practice are an advantage.
- Ideally, you gained knowledge of applicable clinical research regulatory requirements (i.e. GCP, ICH guidelines).
- We expect a high degree of independent working, analytical reasoning, and good communication skills in English.
- Basic knowledge in immunology, oncology and/ or cell and gene therapy is a plus.
We are a committed and inspired team and cherish the collegial, highly motivated and family-friendly atmosphere within Immatics. Our culture allows for a high level of originality, independent thinking and initiative. We believe in supporting our employees' professional and social skills: We enable them to join conferences and trainings as well as to enjoy our Immatics benefits - e.g. job bike, job ticket, Health Programs, childcare benefits, relocation allowance, company summer and winter events.
- We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. Operating from Tuebingen, Munich and Houston, we are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. For more detailed information, visit www.immatics.com.
